Oramed Pharmaceuticals Stock Cycle Indicators Hilbert Transform Trend vs Cycle Mode

ORMP Stock  USD 2.34  0.03  1.30%   
Oramed Pharmaceuticals cycle indicators tool provides the execution environment for running the Hilbert Transform Trend vs Cycle Mode indicator and other technical functions against Oramed Pharmaceuticals. Oramed Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Trend vs Cycle Mode indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Oramed Pharmaceuticals price series.

Indicator
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Trend vs Cycle Mode is Hilbert Transform indicator that generates in-phase and quadrature components of Oramed Pharmaceuticals price series in order to analyze trend vs cycle patterns of Oramed Pharmaceuticals.

Oramed Pharmaceuticals Technical Analysis Modules

Most technical analysis of Oramed Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oramed from various momentum indicators to cycle indicators. When you analyze Oramed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Oramed Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oramed Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oramed Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oramed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oramed Pharmaceuticals's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Oramed Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Oramed Pharmaceuticals, we also check how macroeconomic factors affect Oramed Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Graham Number8.298.7
Receivables Turnover1.880.98
Hype
Prediction
LowEstimatedHigh
0.122.344.68
Details
Intrinsic
Valuation
LowRealHigh
0.222.564.90
Details
Naive
Forecast
LowNextHigh
0.052.324.66
Details
1 Analysts
Consensus
LowTargetHigh
2.873.153.50
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.